Skip to content

Effect of laser on neuropathic pain control in patients with diabetes mellitus

Evaluation of the effect of low-intensity laser on lower limb neuropathic pain in patients with diabetes mellitus.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201009203565N2
Enrollment
30
Registered
2010-10-16
Start date
2009-07-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes. Non-insulin-dependent diabetes mellitus

Interventions

Intervention 1: The real low power laser: Ga.Al. Ars laser with wave length 630 nm. Intervention 2: The unrealistic low power laser as placebo with a similar device but without the real laser.
Rehabilitation
Placebo
The real low power laser: Ga.Al. Ars laser with wave length 630 nm
The unrealistic low power laser as placebo with a similar device but without the real laser

Sponsors

Tabriz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: age more than 18 years, diabetic peripheral polyneuropathy confirmed by electrodiagnostic test, presence of pain with diabetic neuropathy Exclusion criteria: receiving Peripheral analgesic therapies during the study period, unstable systemic illnesses (such as malignancy, uncontrolled thyroid disease, heart failure, disorders in brain circulatory, hematopoietic system disorders, fever with unknown origin, active pulmonary TB), presence of other neurological disorders, presence of pain in other parts of the body, Pregnancy, presence of metal prostheses, drug or alcohol abuse, history of excessive sensitivity to light

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Pain. Timepoint: Every week. Method of measurement: visual analogue scale (VAS).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAkbar Aliasgharzadeha

Tabriz University of Medical Sciences

asgharzadeha@tbzmed.ac.ir+98 41 1336 4032

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026